XZJ-95200-20404
4 vaccinations
8 coded responses
43 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 221 / VA
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 1 — Pfizer-BioNTech
- 2021-03-17
-
2021-03-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-31
-
2021-04-07
Dose 2 — Pfizer-BioNTech
- 2021-04-07
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Chills, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
-
2021-05-12
Survey response — 35 day, dose 2MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-05-19
- 2021-07-07
- 2021-10-06
-
2021-11-11
Dose 3 — Pfizer-BioNTech
-
2021-12-04
Survey response — 21 day, dose 3MedDRA: Axillary pain, Cough, Fatigue, Pyrexia, SARS-CoV-2 test — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11 · check-in answers available
-
2021-12-04
Report sent to call center — 21 day, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-09
- 2021-12-09
-
2021-12-16
Survey response — 35 day, dose 3MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2021-12-23
- 2022-02-12
-
2022-05-14
Survey response — 6 month, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11 · check-in answers available
-
2022-05-14
Report sent to call center — 6 month, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-16
-
2022-05-17
Call successfulCompleted over the phone
-
2022-05-17
Call successfulCompleted over the phone
-
2022-09-20
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-21
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-22
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain — Feeling: FairMedDRA releases: 2024-11 · check-in answers available
- 2022-09-23
-
2022-09-25
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
-
2022-09-26
Survey response — days 1–6 daily, dose 4MedDRA: Flushing — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
- 2022-09-27
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-12-22
-
2023-03-21
Survey response — 6 month, dose 4MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | |
| 2 | 2021-04-07 | Pfizer-BioNTech | |
| 3 | 2021-11-11 | Pfizer-BioNTech | No |
| 4 | 2022-09-20 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-04 | Successful 2022-05-17 |
Completed over the phone |
| 2022-05-14 | Successful 2022-05-17 |
Completed over the phone |
Free text
Release 8
Symptoms: Fatigue. Still able to do things just less than normal. Was very tired. Slept a lot on the weekend and fatigue is starting to lift now.
Release 10
Symptoms: Straight after vaccination I had a fever and pain in the right armpit. A week after vaccination I developed a dry cough and fatigue and pain in right armpit. Two weeks later still have dry cough and pain in right armpit and some fatigue
Healthcare visit (other): Covid test
Symptoms: Fatigue
Release 11
Symptoms: Covid 19
Release 12
Systemic reaction (other): Sore throat
Systemic reaction (other): Swollen lymphnodes
Systemic reaction (other): Flushed face. Flushed arms.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | · | · | ✓ |
| SD | Axillary pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Flushing | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release